Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy
- PMID: 20065860
- DOI: 10.1097/RLI.0b013e3181c7bcda
Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy
Abstract
Objectives: The objective of this study was to assess the feasibility of the combination of magnetic resonance (MR)-guided biopsy (MRGB) and diagnostic 3T MR imaging in the localization of local recurrence of prostate cancer (PCa) after external beam radiation therapy (EBRT).
Materials and methods: Twenty-four consecutive men with biochemical failure suspected of local recurrence after initial EBRT were enrolled prospectively in this study. All patients underwent a diagnostic 3T MR examination of the prostate. T2-weighted and dynamic contrast-enhanced MR images (DCE-MRI) were acquired. Two radiologists evaluated the MR images in consensus for tumor suspicious regions (TSRs) for local recurrence. Subsequently, these TSRs were biopsied under MR-guidance and histopathologically evaluated for the presence of recurrent PCa. Descriptive statistical analysis was applied.
Results: Tissue sampling was successful in all patients and all TSRs. The positive predictive value on a per patient basis was 75% (15/20) and on a per TSR basis 68% (26/38). The median number of biopsies taken per patient was 3, and the duration of an MRGB session was 31 minutes. No intervention-related complications occurred.
Conclusions: The combination of MRGB and diagnostic MR imaging of the prostate was a feasible technique to localize PCa recurrence after EBRT using a low number of cores in a clinically acceptable time.
Similar articles
-
Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.Eur Urol. 2014 Jul;66(1):22-9. doi: 10.1016/j.eururo.2014.03.002. Epub 2014 Mar 14. Eur Urol. 2014. PMID: 24666839
-
Magnetic resonance imaging-guided prostate biopsy: institutional analysis and systematic review.Rofo. 2014 May;186(5):501-7. doi: 10.1055/s-0033-1355546. Epub 2014 Feb 4. Rofo. 2014. PMID: 24497092 Review.
-
Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy.Clin Oncol (R Coll Radiol). 2013 Apr;25(4):252-64. doi: 10.1016/j.clon.2012.11.010. Epub 2013 Jan 11. Clin Oncol (R Coll Radiol). 2013. PMID: 23313568 Review.
-
Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.Invest Radiol. 2008 Oct;43(10):686-94. doi: 10.1097/RLI.0b013e31817d0506. Invest Radiol. 2008. PMID: 18791410
-
Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):425-30. doi: 10.1016/j.ijrobp.2007.06.029. Epub 2007 Sep 19. Int J Radiat Oncol Biol Phys. 2008. PMID: 17881141
Cited by
-
Evaluation of Recurrent Disease after Radiation Therapy for Patients Considering Local Salvage Therapy: Past vs. Contemporary Management.Cancers (Basel). 2023 Dec 18;15(24):5883. doi: 10.3390/cancers15245883. Cancers (Basel). 2023. PMID: 38136427 Free PMC article. Review.
-
Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes.Eur Radiol. 2017 Nov;27(11):4828-4836. doi: 10.1007/s00330-017-4833-9. Epub 2017 Apr 13. Eur Radiol. 2017. PMID: 28409355 Free PMC article.
-
Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer.Urol Oncol. 2016 Jul;34(7):326-32. doi: 10.1016/j.urolonc.2016.03.005. Epub 2016 Apr 12. Urol Oncol. 2016. PMID: 27083114 Free PMC article. Review.
-
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):259-72. doi: 10.1016/j.rpor.2015.04.003. Epub 2015 May 30. Rep Pract Oncol Radiother. 2015. PMID: 26109913 Free PMC article. Review.
-
Correlation between dynamic contrast-enhanced MRI and quantitative histopathologic microvascular parameters in organ-confined prostate cancer.Eur Radiol. 2014 Oct;24(10):2597-605. doi: 10.1007/s00330-014-3301-z. Epub 2014 Jul 18. Eur Radiol. 2014. PMID: 25033819
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical